Abstract
Seven groups of enkephalin-degrading enzymes and three groups of inhibitors active on these enzymes were separated from human plasma. The activity of the enzymes in hydrolyzing enkephalins and of the inhibitors in protecting enkephalins from proteolysis was measured. Results obtained with the endogenous inhibitors were compared to those relative to synthetic inhibitors. Data obtained indicate that all enkephalin-degrading enzymes found in plasma are significantly inhibited by the endogenous substances present in this tissue. The inhibition of the different classes of plasma enzymes by two of the three groups of endogenous substances is quite uniform, while one group of inhibitors appears specific to dipeptidylpeptidases. Results obtained are discussed in terms of the functional role of the inhibitory substances and of the possible pharmacological implication of their presence in human plasma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Clement-Jones, V., Lowry, P. J., Rees, L. H. and Besser, G. M. 1980. Met-enkephalin circulates in human plasma. Nature 283:295–297.
Schultzberg, M., Lundberg, J.M., Hokfelt, T., Terenius, L., Brandt, J., Elde, R. P. and Goldstein, M. (1978) Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla. Neuroscience 3:1169–1186
Hambrook, J. M., Morgan, B. A., Rance, M. J. and Smith, C. F. (1976) Mode of deactivation of the enkephalins by rat and human plasma and by brain homogenates. Nature 262:782–783
Roda, L. G., Venturelli, F. and Roscetti, G. (1986) Hydrolysis and protection from hydrolysis of circulating enkephalins. Comp. Biochem. Physiol. 85C:449–454
Possenti, R., De Marco, V., and Roda, L. G. (1983) Enkephalin-binding systems in human plasma. Neurochem. Res. 81:423–432
Roscetti, G., Venturelli, F. and Roda, L. G. (1988) Enkephalin Binding Systems in Human Plasma III: Comparative Protection of Different Peptides Neurochem. Res 13:221–224
Weinberger, S. B. and Martinez, J. L. Jr. (1988) Differential effects on active avoidance performance and locomotor activity of two major enkephalin metabolites, Tyr-Gly-Gly and Des-Tyr-[Leu] Enkephalin. Life Sci. 43:769–776
Barklay, R. K. and Phillipps, M. A. (1980) Inhibition of the enkephalin-degrading aminopeptidase activity by certain peptides. Biochem. Biophys. Res. Commun. 96:1732–1738
Roques, B. P., Fournié-Zaluski M. C., Soroca, E., Lecomte, J. M., Malfroy, B., Llorens, C. and Schwartz, J. C. (1980) The enkephalinase inhibitor thiorphan shows antinoceptive activity in mice. Nature 288:286–288
Ondetti, M. A., Rubin, B. and Cushman, P. W. (1977) Design of specific inhibitors of angiotensin converting enzyme: a new class of anti-ipertensive agents. Science 196:441–444
Carenzi, A., Frigeni, V., Reggiani, A. e Della Bella, D. On the possibility of influencing Enkephalin System: StudiesIn Vitro andIn Vivo in “Degradation of Endogenous Opioids”, S. Ehrenpreis and F. Sicuteri eds. Raven Press, New York, 1983
Venturelli, F., Roscetti, G., Possenti, R., Vita, F. and Roda, L. G. (1985) Peripheral enkephalin hydrolysis in different animal species: a comparative study. Neurochem. Res. 10:333–342
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marini, M., Roscetti, G., Bongiorno, L. et al. Hydrolysis and protection from hydrolysis of enkephalins in human plasma. Neurochem Res 15, 61–67 (1990). https://doi.org/10.1007/BF00969185
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00969185